The Navigator Company (NVG) Q1 2025 earnings summary

Executive summary

• Q1 2025 delivered solid results amid geopolitical tensions and slowing economic activity, with resilience supported by strategic diversification into tissue and packaging, now accounting for up to 45% of sales.

• International sales in tissue surged, with 81% outside Portugal, and packaging volumes grew 31% year-over-year, driven by acquisitions and product diversification.

• Net profit reached €48 million, up 6% sequentially, and EBITDA was €116 million, maintaining a 22% margin quarter-over-quarter.

• Net Debt/EBITDA ratio stands at 1.25x after €100 million in dividends and €36 million in capex.

• Free cash flow generation remained strong, supporting ongoing investment and financial stability.

Financial highlights

• Turnover for Q1 2025 was €529 million, up 2% sequentially but down 1% year-over-year.

• EBITDA margin at 22%, unchanged from Q4 2024, with net profit up 6% quarter-over-quarter but down 25% year-over-year.

• Net debt increased by €43 million to €660 million, with a Net Debt/EBITDA ratio of 1.25x.

• Capex totaled €36 million, with 60% directed to environmental or sustainability projects.

• Free cash flow was strong, with figures reported at €26 million and €57 million.

Outlook and guidance

• Geopolitical instability and protectionism are expected to persist, increasing risks of global slowdown, inflation, and market volatility.

• US tariffs and mill closures may create opportunities in export markets, with stocks positioned to cover Q3 and part of Q4.

• Adaptability and operational flexibility are emphasized as key to navigating uncertain market conditions.

• Second quarter started with healthy US demand, while European demand has yet to reflect this upturn.